Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:25 pm Purchase |
2024-12-31 | 13G | DBV Technologies S.A. DBVT |
BRAIDWELL LP | 2,393,815 2.500% |
2,393,815 (New Position) |
Filing History |
| 2024-11-14 4:55 pm Purchase |
2024-09-30 | 13G | DBV Technologies S.A. DBVT |
BRAIDWELL LP | 2,032,592 9.990% |
2,032,592 (New Position) |
Filing History |
| 2024-02-14 4:06 pm Sale |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BRAIDWELL LP | 2,385,623 2.920% |
-2,213,861 (-48.13%) |
Filing History |
| 2024-02-14 4:06 pm Sale |
2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
BRAIDWELL LP | 0 0.000% |
-3,469,674 (Position Closed) |
Filing History |
| 2024-02-14 4:06 pm Purchase |
2023-12-31 | 13G | DBV Technologies S.A. DBVT |
BRAIDWELL LP | 494,266 9.990% |
25,152 (+5.36%) |
Filing History |
| 2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | DBV Technologies S.A. DBVT |
BRAIDWELL LP | 469,114 9.990% |
469,114 (New Position) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
BRAIDWELL LP | 3,469,674 6.450% |
3,469,674 (New Position) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BRAIDWELL LP | 4,599,484 6.680% |
4,599,484 (New Position) |
Filing History |